Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!
- PMID: 33241048
- PMCID: PMC7576010
- DOI: 10.21037/atm.2020.04.57
Adjuvant treatment with EGFR TKI in resected non-small cell lung cancer with EGFR mutation: all that glitters is not gold!
Conflict of interest statement
Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/atm.2020.04.57). The authors have no conflicts of interest to declare.
Comment on
-
Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition).Transl Lung Cancer Res. 2019 Dec;8(6):1163-1173. doi: 10.21037/tlcr.2019.12.14. Transl Lung Cancer Res. 2019. PMID: 32010594 Free PMC article. Review. No abstract available.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous